J&J Polishes SAPPHIRE Carotid Trial For HCFA Conditional Coverage Appraisal
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson Cordis plans to submit an investigational device exemption application to FDA in March or April for the SAPPHIRE carotid stent trial, as discussions continue with the Health Care Financing Administration to secure reimbursement coverage.